Gas exchange at extreme altitude: results from the British 40th Anniversary Everest Expedition

Since Messner and Habeler climbed to the summit of Mount Everest (8,848 m) without oxygen in 1978, there has been controversy between scientists trying to explain this feat. Field studies have suggested better respiratory performance than that found during a simulated climb in a hypobaric chamber, but the lack of data at extreme altitude has hampered the debate. We measured arterial oxygen saturation (Sa,O2) and alveolar partial pressure of oxygen (PA,O2) in nine subjects as they climbed from 3,500 to 8,000 m. Four of the climbers reached 8,000 m and one reached the summit. We also tested the effects of breathing supplementary oxygen on Sa,O2 at 6,550 and 8,000 m. At all altitudes tested, we found that both PA,O2 and Sa,O2 were higher than expected from low pressure chamber studies. We also found that standard rates of supplementary oxygen (2 L x min(-1)) were insufficient to restore Sa,O2 above 90% at 8,000 m. The respiratory performance of climbers at extreme altitude is better than expected from sea-level chamber studies, which may, in part, explain why humans can reach the summit (8,848 m) without added oxygen. The better performance is likely to be due to more appropriate acclimatization.

This article has been cited by other articles:

				B R O'Driscoll, L S Howard, A G Davison, and on behalf of the British Thoracic Society BTS guideline for emergency oxygen use in adult patients Thorax, October 1, 2008; 63(Suppl_6): vi1 - vi68. [Full Text] [PDF]

				E. A. Tansey Teaching the physiology of adaptation to hypoxic stress with the aid of a classic paper on high altitude by Houston and Riley Advan Physiol Educ, March 1, 2008; 32(1): 11 - 17. [Abstract] [Full Text] [PDF]

				J. B. West The Physiologic Basis of High-Altitude Diseases Ann Intern Med, November 16, 2004; 141(10): 789 - 800. [Full Text] [PDF]

				S Grant, N MacLeod, J W Kay, M Watt, S Patel, A Paterson, and A Peacock Sea level and acute responses to hypoxia: do they predict physiological responses and acute mountain sickness at altitude? Br. J. Sports Med., April 1, 2002; 36(2): 141 - 146. [Abstract] [Full Text] [PDF]

				R. B. Huey and X. Eguskitza Limits to human performance: elevated risks on high mountains J. Exp. Biol., March 11, 2002; 204(18): 3115 - 3119. [Abstract] [Full Text] [PDF]

				N. Kinoshita, H. Yamazaki, S. Onishi, Y. Oguma, F. Katsukawa, and M. Horii Physiological Profile of Middle-Aged and Older Climbers Who Ascended Gasherbrum II, an 8035-m Himalayan Peak J. Gerontol. A Biol. Sci. Med. Sci., November 1, 2000; 55(11): 630M - 633. [Abstract] [Full Text]

				R. B. Huey and X. Eguskitza Supplemental Oxygen and Mountaineer Death Rates on Everest and K2 JAMA, July 12, 2000; 284(2): 181 - 181. [Full Text] [PDF]